Lupin logo

LUPIN - Lupin News Story

₹1196.75 -1.6  -0.1%

Last Trade - 10:05am

Sector
Healthcare
Size
Large Cap
Market Cap £5.32bn
Enterprise Value £5.52bn
Revenue £1.49bn
Position in Universe 80th / 3105

BUZZ-India's Lupin sees worst day in month after co posts Sept-qtr loss

Thu 7th November, 2019 6:36am
** Shares of pharmaceutical company Lupin Ltd  LUPN.NS  fall
as much as 4.5% to 736.7 rupees, their biggest intra-day
percentage fall in a month after the firm reported a Q2 loss
    ** Reports Q2 consol net loss of 1.27 bln rupees ($17.89
mln), stemming from a 5.46 bln rupee exceptional item related to
a lawsuit settlement and divestiture-related loss  urn:newsml:reuters.com:*:nFWN27M0RW
    ** Exceptional item includes $53 mln provision related to
lawsuit settlement in Texas and a 1.67 billion rupees loss
linked to divestiture of Kyowa CritiCare Co Ltd 
    ** Motilal Oswal Securities cuts EPS estimate by 6% to 27
rupees for FY 20 and trims EPS estimate for FY 21 by 2% to 38.5
rupees
    ** About 2.8 mln shares change hands vs 30-day moving
average of 1.4 mln shares   
    ** Shares down 8.63% this year, as of last close
    
    ($1 = 71.0025 Indian rupees)
    

 (Reporting by Philip George in Bengaluru)
 ((P.George@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6749 1609; Reuters Messaging:
p.george@thomsonreuters.net))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.